Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0473 Transporter Info
Gene Name	SLC7A6
Transporter Name	Y+L amino acid transporter 2
Gene ID	9057
UniProt ID	Q92536

Post-Translational Modification of This DT
Overview of SLC7A6 Modification Sites with Functional and Structural Information
Sequence	M E A R E P G R P T P T Y H L V P N T S Q S Q V E E D V S S P P Q R S S E T M Q L K K E I S L L N G V S L V V G N M I G S G I F V S P K G V L V H T A S Y G M S L I V W A I G G L F S V V G A L C Y A E L G T T I T K S G A S Y A Y I L E A F G G F I A F I R L W V S L L V V E P T G Q A I I A I T F A N Y I I Q P S F P S C D P P Y L A C R L L A A A C I C L L T F V N C A Y V K W G T R V Q D T F T Y A K V V A L I A I I V M G L V K L C Q G H S E H F Q D A F E G S S W D M G N L S L A L Y S A L F S Y S G W D T L N F V T E E I K N P E R N L P L A I G I S M P I V T L I Y I L T N V A Y Y T V L N I S D V L S S D A V A V T F A D Q T F G M F S W T I P I A V A L S C F G G L N A S I F A S S R L F F V G S R E G H L P D L L S M I H I E R F T P I P A L L F N C T M A L I Y L I V E D V F Q L I N Y F S F S Y W F F V G L S V V G Q L Y L R W K E P K R P R P L K L S V F F P I V F C I C S V F L V I V P L F T D T I N S L I G I G I A L S G V P F Y F M G V Y L P E S R R P L F I R N V L A A I T R G T Q Q L C F C V L T E L D V A E E K K D E R K T D
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A6			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	20
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 20 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC7A6			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	22
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 22 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC7A6			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 29 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC7A6			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 30 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC7A6			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	35
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 35 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC7A6			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 36 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC7A6			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	347
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Serine 347 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A6			[3] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Threonine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC7A6			[3] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	12
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Threonine 12 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC7A6			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Threonine 19 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC7A6			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	38
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Threonine 38 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A6			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A6 Tyrosine 13 has the potential to affect its expression or activity.

References
1	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
2	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
3	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
4	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
5	Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. Mol Biol Cell. 2018 May 1;29(9):1031-1047.
6	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
7	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
8	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
9	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence